Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 247


Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration.

Cherepanova OA, Pidkovka NA, Sarmento OF, Yoshida T, Gan Q, Adiguzel E, Bendeck MP, Berliner J, Leitinger N, Owens GK.

Circ Res. 2009 Mar 13;104(5):609-18. doi: 10.1161/CIRCRESAHA.108.186064. Epub 2009 Jan 22.


Kruppel-like factor 4, Elk-1, and histone deacetylases cooperatively suppress smooth muscle cell differentiation markers in response to oxidized phospholipids.

Yoshida T, Gan Q, Owens GK.

Am J Physiol Cell Physiol. 2008 Nov;295(5):C1175-82. doi: 10.1152/ajpcell.00288.2008. Epub 2008 Sep 3.


Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro.

Pidkovka NA, Cherepanova OA, Yoshida T, Alexander MR, Deaton RA, Thomas JA, Leitinger N, Owens GK.

Circ Res. 2007 Oct 12;101(8):792-801. Epub 2007 Aug 17.


Oxidized phospholipid species promote in vivo differential cx43 phosphorylation and vascular smooth muscle cell proliferation.

Johnstone SR, Ross J, Rizzo MJ, Straub AC, Lampe PD, Leitinger N, Isakson BE.

Am J Pathol. 2009 Aug;175(2):916-24. doi: 10.2353/ajpath.2009.090160. Epub 2009 Jul 16.


Cooperative binding of KLF4, pELK-1, and HDAC2 to a G/C repressor element in the SM22α promoter mediates transcriptional silencing during SMC phenotypic switching in vivo.

Salmon M, Gomez D, Greene E, Shankman L, Owens GK.

Circ Res. 2012 Aug 31;111(6):685-96. doi: 10.1161/CIRCRESAHA.112.269811. Epub 2012 Jul 18.


Differential effects of chlorinated and oxidized phospholipids in vascular tissue: implications for neointima formation.

Greig FH, Hutchison L, Spickett CM, Kennedy S.

Clin Sci (Lond). 2015 May;128(9):579-92. doi: 10.1042/CS20140578.


PDGF-DD, a novel mediator of smooth muscle cell phenotypic modulation, is upregulated in endothelial cells exposed to atherosclerosis-prone flow patterns.

Thomas JA, Deaton RA, Hastings NE, Shang Y, Moehle CW, Eriksson U, Topouzis S, Wamhoff BR, Blackman BR, Owens GK.

Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H442-52. doi: 10.1152/ajpheart.00165.2008. Epub 2008 Nov 21.


Increased atherosclerosis and vascular smooth muscle cell activation in AIF-1 transgenic mice fed a high-fat diet.

Sommerville LJ, Kelemen SE, Ellison SP, England RN, Autieri MV.

Atherosclerosis. 2012 Jan;220(1):45-52. doi: 10.1016/j.atherosclerosis.2011.07.095. Epub 2011 Aug 6.


C/EBP-Homologous Protein (CHOP) in Vascular Smooth Muscle Cells Regulates Their Proliferation in Aortic Explants and Atherosclerotic Lesions.

Zhou AX, Wang X, Lin CS, Han J, Yong J, Nadolski MJ, Borén J, Kaufman RJ, Tabas I.

Circ Res. 2015 May 22;116(11):1736-43. doi: 10.1161/CIRCRESAHA.116.305602. Epub 2015 Apr 14.


Import and fate of fluorescent analogs of oxidized phospholipids in vascular smooth muscle cells.

Moumtzi A, Trenker M, Flicker K, Zenzmaier E, Saf R, Hermetter A.

J Lipid Res. 2007 Mar;48(3):565-82. Epub 2006 Nov 29.


The promoter activity of human Mfn2 depends on Sp1 in vascular smooth muscle cells.

Sorianello E, Soriano FX, Fernández-Pascual S, Sancho A, Naon D, Vila-Caballer M, González-Navarro H, Portugal J, Andrés V, Palacín M, Zorzano A.

Cardiovasc Res. 2012 Apr 1;94(1):38-47. doi: 10.1093/cvr/cvs006. Epub 2012 Jan 17.


Cyclosporine up-regulates Krüppel-like factor-4 (KLF4) in vascular smooth muscle cells and drives phenotypic modulation in vivo.

Garvey SM, Sinden DS, Schoppee Bortz PD, Wamhoff BR.

J Pharmacol Exp Ther. 2010 Apr;333(1):34-42. doi: 10.1124/jpet.109.163949. Epub 2010 Jan 20.


Deletion of Krüppel-like factor 4 in endothelial and hematopoietic cells enhances neointimal formation following vascular injury.

Yoshida T, Yamashita M, Horimai C, Hayashi M.

J Am Heart Assoc. 2014 Jan 27;3(1):e000622. doi: 10.1161/JAHA.113.000622.


Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position.

Subbanagounder G, Leitinger N, Schwenke DC, Wong JW, Lee H, Rizza C, Watson AD, Faull KF, Fogelman AM, Berliner JA.

Arterioscler Thromb Vasc Biol. 2000 Oct;20(10):2248-54.


Inhibition of oxidized-phospholipid-induced vascular smooth muscle cell proliferation by resveratrol is associated with reducing Cx43 phosphorylation.

Shi Y, Hou X, Zhang X, Wang Y, Chen Y, Zou J.

J Agric Food Chem. 2013 Nov 6;61(44):10534-41. doi: 10.1021/jf4036723. Epub 2013 Oct 22.


Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils.

Leitinger N, Tyner TR, Oslund L, Rizza C, Subbanagounder G, Lee H, Shih PT, Mackman N, Tigyi G, Territo MC, Berliner JA, Vora DK.

Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):12010-5.


Elongation of Long-Chain Fatty Acid Family Member 6 (Elovl6)-Driven Fatty Acid Metabolism Regulates Vascular Smooth Muscle Cell Phenotype Through AMP-Activated Protein Kinase/Krüppel-Like Factor 4 (AMPK/KLF4) Signaling.

Sunaga H, Matsui H, Anjo S, Syamsunarno MR, Koitabashi N, Iso T, Matsuzaka T, Shimano H, Yokoyama T, Kurabayashi M.

J Am Heart Assoc. 2016 Nov 23;5(12). pii: e004014.


Oxidized phospholipids in minimally modified low density lipoprotein induce apoptotic signaling via activation of acid sphingomyelinase in arterial smooth muscle cells.

Loidl A, Sevcsik E, Riesenhuber G, Deigner HP, Hermetter A.

J Biol Chem. 2003 Aug 29;278(35):32921-8. Epub 2003 Jun 19.


Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle.

Deaton RA, Gan Q, Owens GK.

Am J Physiol Heart Circ Physiol. 2009 Apr;296(4):H1027-37. doi: 10.1152/ajpheart.01230.2008. Epub 2009 Jan 23.


Flank sequences of miR-145/143 and their aberrant expression in vascular disease: mechanism and therapeutic application.

Liu X, Cheng Y, Yang J, Qin S, Chen X, Tang X, Zhou X, Krall TJ, Zhang C.

J Am Heart Assoc. 2013 Oct 28;2(6):e000407. doi: 10.1161/JAHA.113.000407.

Supplemental Content

Support Center